Revenues for the three months ended
Revenues for the six months ended
Subsequent Event - Private Placement
As previously reported, on
On
Complete financial results are available in the Company's Quarterly Report on Form 10Q for
Financial Highlights
| Three Months Ended | Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Net revenues | $ | 941,671 | $ | 887,498 | $ | 1,807,926 | $ | 1,861,173 | ||||||||
Cost of sales | $ | 432,783 | $ | 511,701 | $ | 903,988 | $ | 1,004,083 | ||||||||
Gross Profit | $ | 508,888 | $ | 375,797 | $ | 903,938 | $ | 857,090 | ||||||||
Total operating expenses | $ | 362,238 | $ | 373,244 | $ | 777,943 | $ | 745,303 | ||||||||
Income (loss) from operations | $ | 146,650 | $ | 2,553 | $ | 125,995 | $ | 111,787 | ||||||||
Total other income (expense) | $ | 5,989 | $ | (117,225 | ) | $ | 49,030 | $ | 102,675 | |||||||
Net income (loss) | $ | 140,661 | $ | (114,672 | ) | $ | 173,025 | $ | 212,962 | |||||||
Basic and diluted per common share | $ | 0.00 | $ | (0.00 | ) | $ | 0.00 | $ | 0.00 | |||||||
Weighted average shares of common stock outstanding - basic and diluted | 67,588,492 | 67,588,492 | 67,588,492 | 67,588,492 | ||||||||||||
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, and FDA-Registered and ISO-13485 Certified medical device development and manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for the research, development and commercialization of diversified technologies. Additional information is available at admtronics.com.
ADMT welcomes inquiries for its electronics and medical device contract engineering and manufacturing services at www.admteng.com.
To receive ADMT email updates, complete the form at https://admtronics.com/investor-relations/.
Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact: Andre DiMino - 201-767-6040 - andre@admtronics.com
SOURCE: ADM Tronics Unlimited Inc.
View the original press release on ACCESS Newswire